Related Experiment Video
Updated: Jun 15, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral
M Sidorkiewicz1, M Grek, B Jozwiak
1Department of Medical Biochemistry, Medical University of Lodz, ul. Mazowiecka 6/8, Lodz, Poland. msidor@zdn.am.lodz.pl
Insights
Hepatitis C virus (HCV) RNA persistence after treatment correlates with BIC expression in peripheral blood mononuclear cells (PBMCs). High BIC levels indicate ongoing infection, while clearance is linked to lower BIC expression.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis, hepatocellular carcinoma, and extra-hepatic diseases.
- HCV RNA persistence in serum and peripheral blood mononuclear cells (PBMCs) is frequently observed post-treatment.
- BIC, the precursor of microRNA-155 (miR-155), is implicated as a potential factor influencing HCV infection course.
Purpose of the Study:
- To investigate the relationship between BIC expression and HCV RNA status in treated patients.
- To determine if BIC expression levels correlate with viral clearance in serum and PBMCs.
Main Methods:
- Assessed BIC expression in PBMCs and HCV RNA in serum and PBMCs from 64 patients treated with interferon alpha (IFN-alpha) + ribavirin.
- Categorized patients based on HCV RNA status: persistent in both, cleared from serum only, or cleared from both.
Main Results:
- 100% of patients with detectable HCV RNA in both serum and PBMCs showed high BIC expression.
- 83% of patients who cleared HCV RNA from serum but not PBMCs were BIC-positive.
- The lowest BIC expression was observed in patients who cleared HCV RNA from both serum and PBMCs.
Conclusions:
- BIC expression in PBMCs is strongly associated with HCV RNA status.
- High BIC expression may serve as a biomarker for persistent HCV infection even after treatment.
- Monitoring BIC levels could offer insights into HCV clearance dynamics.
Abstract:
Chronic hepatitis caused by Hepatitis C virus (HCV) is the main source of liver cirrhosis, hepatocellular carcinoma, and extra-hepatic diseases. After treatment-induced resolution of hepatitis C, the persistence of HCV RNA in serum and peripheral blood mononuclear cells (PBMCs) is often observed. An expression of the precursor of microRNA-155 (miR-155) called BIC can be the factor responsible for a course of HCV infection. Therefore, we assessed the relationship between BIC expression and HCV RNA status in sera and PBMCs samples of 64 hepatitis C patients treated with interferon alpha(IFN-alpha)+ribavirin. High expression of BIC in PBMCs was determined in 100% of patients that harbored HCV RNA in serum and PBMCs. Further, we found that 83% of PBMCs samples were BIC-positive in a group of patients that eliminated HCV RNA only from serum. The lowest expression of BIC was found in patients that eliminated HCV RNA from both serum and PBMCs.
Related Concept Videos
Hepatitis
MicroRNAs
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis

